Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
New words:
analyze, assigned, assignment, begun, Canadian, Cape, component, Coral, deferral, detailed, Dowd, EBOL, element, employment, enable, Experimental, Gaithersburg, Geller, guidance, hereof, LLP, met, moved, moving, Municipal, original, overhead, Police, prospectively, reissued, retention, Retirement, retrospective, Rudman, site, situation, standard, Sunrise, taxpayer, thereunder, transition, transitional, underutilized, world
Removed:
ADAPTIR, ADAPTIRTM, AG, Alzheimer, autoimmune, bleeding, called, cancer, centralized, characterization, chickenpox, children, Chronic, coagulation, confer, constructed, contemplated, disorder, dry, HDN, hemolytic, hemophilia, HepaGam, higher, immunotherapeutic, ITP, IX, IXINITY, launch, Leukemia, Lymphocytic, managed, maximum, metastatic, modular, MVA, newborn, otlertuzumab, platelet, prophylactic, prostate, protein, purpura, qualification, recent, reportable, SDF, subsidiary, thirteen, thrombocytopenic, transplantation, validating, varicella, VARIZIG, WinRho, zoster
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view